Benjamin Buller

Benjamin Buller has a long and varied work experience in the field of neuroscience. In 2021, they began their current role as Director of Translational Research at NeuroTrauma Sciences, LLC. From 2018-2021, they were a Consultant and Scientific Advisor at NeurExo Sciences. From 2015-2018, they served as Chief Scientific Officer at Forever Labs Inc, where they worked to ensure access to young and healthy mesenchymal stem cells. From 2014-2015, they were an Adjunct Assistant Professor at Oakland University. From 2006-2014, they were an Associate Scientist in the Department of Neurology at the Henry Ford Health System, where they are co-inventor of a novel, exosome-based treatment of neural injury.

Benjamin Buller obtained a Doctor of Philosophy (Ph.D.) in Medical Physics from Oakland University between 2006 and 2010. Prior to that, they earned a Bachelor's Degree in Mechanical Engineering from Oakland University between 2002 and 2005.